Open AccessS732 Comparative Long-Term Drug Survival of First-Line Biologic Agents for Ulcerative Colitis
Author(s) -
Rahul S. Dalal,
Emma McClure,
Jessica R. Allegretti
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776460.62102.94
Subject(s) - medicine , discontinuation , ulcerative colitis , infliximab , vedolizumab , colectomy , adalimumab , proportional hazards model , retrospective cohort study , adverse effect , surgery , disease